POTOMAC, MD/ ACCESS Newswire/ October 13, 2026/ IGC Pharma, Inc., a clinical-stage biotechnology company advancing Alzheimer's disease therapeutics and Artificial Intelligence- enabled healthcare technologies, today announced the introduction of PRISM, a new application layer designed to bring its patent-pending MINT-AD Alzheimer's AI platform closer...
This is the newest page. Registered accounts read further back.